Serina Therapeutics Inc
(SER)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 380 | 388 | 313 | 380 | 464 |
| Cost of Goods | 53 | 63 | 180 | -4 | 79 |
| Gross Profit | 327 | 325 | 133 | 384 | 385 |
| Operating Expenses | 3,822 | 3,510 | 3,671 | 2,582 | 2,598 |
| Operating Income | -3,442 | -3,122 | -3,358 | -2,202 | -2,134 |
| Other Income | 290 | -16 | 84 | 17 | 183 |
| Pre-tax Income | -3,152 | -3,138 | -3,274 | -2,185 | -1,951 |
| Income Tax | 3 | 73 | 0 | N/A | N/A |
| Net Income Continuous | -3,155 | -3,211 | -3,186 | -2,185 | -1,951 |
| Minority Interests | -66 | -78 | -88 | -34 | -21 |
| Net Income | $-3,089 | $-3,133 | $-3,186 | $-2,151 | $-1,930 |
| EPS Basic Total Ops | -2.82 | -3.17 | -3.17 | -2.11 | -2.11 |
| EPS Basic Continuous Ops | -2.95 | -3.13 | -3.13 | -2.15 | -2.01 |
| EPS Diluted Total Ops | -2.82 | -3.17 | -3.17 | -2.11 | -2.11 |
| EPS Diluted Continuous Ops | -2.95 | -3.13 | -3.13 | -2.15 | -2.01 |
| EBITDA(a) | $-3,191 | $-2,973 | $-3,208 | $-2,056 | $-2,017 |